We help Atlantic Canada companies, industries and researchers use genomic insights and innovations to solve real-world problems.

Impactful investments

Genome Atlantic has consistently strived to drive meaningful impact through all our activities. Realizing the importance of quantifying this impact, we recently enlisted The Evidence Network to conduct a comprehensive Impact Assessment spanning the five-year period from 2018 to 2023. Their findings pointed to a remarkable return on investment and tangible outcome:

  • Every public sector dollar invested in Genome Atlantic yielded $23 in applied R&D investment and $59 to GDP.
  • Genome Atlantic’s efforts enabled $60 million in new impact-driven genomics R&D – of which $21 million or roughly 30%, was private sector investment.
  • Total funds attracted by and invested in Genome Atlantic during the last five years resulted in an estimated $178.7 million of output, $122.2 million contributions to GDP, $8.9 million in provincial and federal tax revenues, and 927 jobs.

Please take a few minutes to read our Impact Assessment. Though concise, the report is packed with compelling data highlighting Genome Atlantic’s crucial role as a key driver of innovation and impact within Atlantic Canada.

Genome Atlantic is proud of our contributions to the region’s prosperity and well-being. Our accomplishments are made possible by the support and dedication of our project partners and government funders at both federal and provincial levels, whose collaboration has been pivotal in driving our shared success.

Untitled design 2023 03 10t090115. 683 e1678453312746

Steve Armstrong, PhD
President & CEO
Genome Atlantic

Impacts At A Glance:

Nova Scotia

Play Video

An update on our Impacts from our President and CEO Steve Armstrong

When MSX was first detected in P.E.I.’s Bedeque Bay in July 2024, alarm bells rang across Maritime Canada’s oyster sector. Now confirmed in New Brunswick too, the parasite threatens a regional industry valued at $58 million in P.E.I. alone. For Dr. Martin Mallet, co-owner of L’Étang Ruisseau Bar Ltée (ERB)/Mallet Oysters in Shippagan — the Maritimes’ largest oyster seed supplier — the best line of defence is clear: selective breeding powered by genomics. Genome Canada recently announced a $3.1M Genome Atlantic project  to support this work and put MSX-resistant seed in the hands of growers, faster.  Check out our press release and video interview with Dr. Mallet who is co-leading this initiative.

Genomics-driven selective breeding is key to developing MSX-resistant oyster seed — a vital long-term solution for the industry. But genomics is also being deployed for short-term solutions.  Through Genome Canada’s $800,000 eDNA Surveillance Initiative, Genome Atlantic is leading a regional project to develop early detection tools for MSX and Dermo in oyster-growing areas. Check out our video and news release about the project.

In Cape Breton’s Bras d’Or Lake, a genomics-powered comeback is underway. Biologist Dr. Rod Beresford is working with First Nations groups and other local experts to combine cutting-edge science with traditional knowledge in a bid to revive oyster operations devastated by MSX disease more than 20 years ago. With support from Genome Atlantic and others, Dr. Beresford is developing rapid detection tools using eDNA and exploring new growing methods – offering fresh hope for the industry and drawing strength from the insights of those who know the lake best. Check out our video and article to find out more.

One in fifty Atlantic Canadians has bipolar disorder, a complex mental illness with strong genetic links. A team of Dalhousie University mental health researchers supported by Genome Atlantic are exploring the role that genetics plays in bipolar disorder (See Case Study 1) with the aim to develop a simple test to identify who is at risk for developing bipolar – and thus begin important interventions sooner. The research team is currently developing and testing early interventions based on their findings.

Genome Atlantic, in partnership with the Verschuren Centre for Sustainability in Energy and the Environment, recently launched a new fund to help companies and researchers to address clean technology challenges and opportunities. Despite the program’s cap of $15,000 per project, its impacts have been profound. We invite you to read about how three women-led startups – Dispersa, Material Futures, and Liven Proteins – used their program funding to harness genomic solutions for developing clean technologies. (See Case Study 4.)

Selective breeding has long been a valuable tree improvement tool for the forestry industry. Through conventional breeding, it takes 20-30 years to complete a cycle of selective breeding. Enter genomics, a game-changing suite of tools, methods and technologies that requires only five years to select the best traits. Recognizing the need for a coordinated approach to genomics research in tree improvement, Genome Atlantic helped to set up the Atlantic Tree Improvement Council (AtlanTIC). (See Case Study 3.)Through AtlanTIC, industry, government, and researchers in all four Atlantic provinces can coordinate large-scale research initiatives with test sites across the region –- sharing the latest advances in tree improvement to benefit the industry across Atlantic Canada.

A Dalhousie University research team has partnered with Genome Atlantic and Prince Edward Island mussel producer Atlantic Aqua Farms on a $3.4M Genome Atlantic R&D project announced in December 2023 to develop Canada’s first-ever genomics selective breeding program for a meatier variety called the triploid mussel. Triploid musses are faster-growing, meatier and more resistant to climate change – and because they grow faster, they can boost production without the need to increase water leases.

Genomics is a green technology that is helping Atlantic Canadian companies and industries to grow more sustainably and to reduce their carbon footprint. Please watch our new video Genomics and Sustainability, to find out how Genome Atlantic’s work across the region is helping to strengthen our natural resource industries and shape a greener, better future.

Aquaculture is crucial to Atlantic Canada’s Blue Economy and food security. Viral diseases threaten fish health and the industry’s sustainable growth – a threat that can be reduced by formulating fish feeds that are sustainably sourced and that help keep fish healthy. Genome Atlantic, in partnership with the Ocean Frontier Institute of Halifax, is providing seed funding to scientists at Memorial and Dalhousie universities who will explore the use of microbial oils in fish feed. Microbial oils have a low carbon footprint and high nutritional value due to their high concentration of omega-3 fatty acids. The research will focus on their effects on fish immunity, an important next step in determining their viability for widespread adoption in aquaculture practices.

Genomics training capacity is crucial because it empowers individuals with the knowledge and skills necessary to drive innovations that benefit health, the economy, and the environment. Yet, training opportunities in genomics are limited in Atlantic Canada and across the country. To address this gap, Genome Atlantic is partnering with the New Brunswick Community College (NBCC) to conduct a needs assessment for genomics capacity in the region. This needs assessment is an important first step towards the goal of developing genomics training components to the NBCC program.

More Related News and Updates

Sign up for our free newsletter.

We will deliver SEQUENCE to your inbox. SEQUENCE highlights the latest genomics applications and research initiatives in Atlantic Canada. Subscribe to stay informed.

Read recent issues here.

Sign up for our free newsletter.

We will deliver SEQUENCE to your inbox. SEQUENCE highlights the latest genomics applications and research initiatives in Atlantic Canada. Subscribe to stay informed.

Read recent issues here.

What Our Clients Say?

“Access to genomic technology and the opportunity to work with genome Atlantic are crucial to the success of our program which has long term implication for both our company and the developing oyster industry.”

Dr. André Mallet

President, L’Étang Ruisseau Bar Ltd., Shippagan, N.B.

We benefit from the stimulus and interest that Genome Atlantic provides… what they bring is indispensible.

Dr. Mark Skinner

Marine Ecology Technical Leader for Canada, Stantec

Partners

Projects Happening In Atlantic Canada

Featured Videos